The PMCQ presents:
LET’S DISCUSS WHAT’S NEW AT THE PCPA
Attendees of the April 21st PMCQ event can expect an evening of engaging discussions, questions and interactions with a distinguished panel of experts.
$75 for members
$125 for non-members
For members and non-members, click here to register.
FREE! For the following educational sponsoring companies
Bristol Myers Squibb
If you are an employee of one of the above educational sponsoring companies, click here to register via E-Mail.
Bill Dempster, from 3Sixty Public Affairs, will kick off the evening panel discussion with a high-level introduction to issues such as the recent IBM report on PCPA, the challenges raised by Second-Entry Biologics (SEBs) and a quick review of what’s happened in the PCPA since last year.
From Nova Scotia PharmaCare, Brad Alyward joins us for an update on the imminent setup of the PCPA secretariat and the next steps in terms of governance and negotiations.
Mr François Noël will introduce a quick discussion on Quebec’s recent proposal to enter into agreements and what this entails from a legal point of view.
Finally we have the pleasure of welcoming for a second year in a row Ghislain Boudreau, VP Public Affairs at Pfizer Canada who will be able to comment on the industry’s point of view on the various topics that are being discussed through the evening.
Thank You to our Educational Partners